Neurology Alert (Vol. 35, No. 6) - February 1, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: February 2016

Valid through: February 2019

Target Audience

This activity is intended for the neurologist.

Subjects

  • Inflammatory Cerebral Amyloid Angiopathy: Can We Avoid the Biopsy?
  • Pregnancy Outcomes in Patients with Neuromyelitis Optica Spectrum Disorders
  • Prevalence and Progression of Epilepsy
    in Adults with Mitochondrial Disease
  • Idiopathic Phrenic Neuropathy
  • ICH May Clinically Mimic TIA
  • Optimal Antiplatelet Therapy for Secondary Prevention of Ischemic Stroke
  • Treatment of AVM-related Epilepsy

Objectives

  • Discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • Discuss the pathogenesis and treatment of pain
  • Describe the basic science of brain function
  • Discuss new information regarding new drugs for commonly diagnosed neurological conditions

Credit Available

Physicians

  • Maximum of 2.25 AMA PRA Category 1 Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Joseph E. Safdieh, MD, Vice Chair and Associate Professor, Weill Cornell Medical College

Jai S. Perumal, MD, Assistant Professor of Neurology, Weill Cornell Medical College

Kimberly Pargeon, MD, Assistant Professor of Clinical Neurology, Weill Cornell Medical College

Michael Rubin, MD, Professor of Clinical Neurology, Weill Cornell Medical College

Alan Z. Segal, MD, Associate Professor of Clinical Neurology, Weill Cornell Medical College

Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

Editors

Medical Editor: Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

AHC Media Executive Editor: Leslie G. Coplin

Managing Editor: Jonathan Springston

Financial Disclosure

Author Jai S. Perumal, MD reports she receives grant/research support from Genzyme Corp. and is on the speakers bureau for Biogen Idec, Teva Pharmaceuticals, Genzyme Corp. and Acorda Therapeutics. Editor Matthew E. Fink, MD reports he is a retained consultant for Procter & Gamble and Pfizer.  

Authors Joseph E. Safdieh, MD; Kimberly Pargeon, MD; Michael Rubin, MD; and Alan Z. Segal, MD; report no financial relationships relevant to this field of study.

Neurology Alert's editor in chief, Matthew E. Fink, MD reports he is a retained consultant for Procter & Gamble and Pfizer. Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and associate managing editor Jonathan Springston report no financial relationships relevant to this field of study.

Copyright 2016, AHC Media. All rights reserved.